RegeneRx Biopharmaceuticals, Inc.
RGRX · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$1,727 | -$1,598 | -$1,523 | -$1,404 |
| Dep. & Amort. | $0 | $0 | $0 | $1 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $512 | $398 | $332 | $270 |
| Change in WC | $39 | $30 | $22 | -$110 |
| Other Non-Cash | $236 | $179 | $162 | $105 |
| Operating Cash Flow | -$941 | -$990 | -$1,007 | -$1,138 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $555 | $1,300 |
| Stock Issued | $0 | $1,759 | $242 | $241 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $35 | -$2 | $241 |
| Financing Cash Flow | $0 | $1,794 | $795 | $1,541 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$941 | $804 | -$212 | $403 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,232 | $428 | $640 | $237 |
| End Cash | $291 | $1,232 | $428 | $640 |
| Free Cash Flow | -$941 | -$990 | -$1,007 | -$1,138 |